Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Trellus Health. (TRLS) Share Price

Price 0.55p on 02-12-2025 at 14:35:07
Change 0.00p 0%
Buy 0.60p
Sell 0.50p
Last Trade: Sell 79,341.00 at 0.5275p
Day's Volume: 129,383
Last Close: 0.55p
Open: 0.55p
ISIN: GB00BNNFM402
Day's Range 0.55p - 0.55p
52wk Range: 0.35p - 4.95p
Market Capitalisation: £888.30k
VWAP: 0.550706p
Shares in Issue: 161.51m

Trellus Health. (TRLS) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 79,341 0.5275p Ordinary
13:06:46 - 02-Dec-25
Buy* 50,042 0.5875p Ordinary
08:00:31 - 02-Dec-25
Sell* 90,133 0.5275p Ordinary
14:56:25 - 01-Dec-25
Sell* 71,739 0.5275p Ordinary
10:37:56 - 28-Nov-25
Buy* 85,762 0.59p Ordinary
13:56:35 - 27-Nov-25
Sell* 46 0.525p Ordinary
12:15:42 - 27-Nov-25
Buy* 44,321 0.59p Ordinary
08:11:48 - 27-Nov-25
Buy* 100,000 0.565p Ordinary
08:11:28 - 27-Nov-25
Buy* 250,000 0.565p Ordinary
08:08:45 - 27-Nov-25
Buy* 500,000 0.57p Ordinary
11:21:17 - 26-Nov-25
See more Trellus Health. trades

Trellus Health. (TRLS) Share Price History

Time period:
to
Date Open High Low Close Volume
2nd Dec 2025 (Tue) 0.55 0.55 0.55 0.55 129,383
1st Dec 2025 (Mon) 0.55 0.55 0.55 0.55 90,133
28th Nov 2025 (Fri) 0.55 0.55 0.55 0.55 71,739
27th Nov 2025 (Thu) 0.55 0.55 0.55 0.55 480,129
26th Nov 2025 (Wed) 0.60 0.60 0.45 0.55 4,922,408
25th Nov 2025 (Tue) 0.65 0.65 0.60 0.60 77,040
24th Nov 2025 (Mon) 0.60 0.65 0.60 0.65 1,029,785
21st Nov 2025 (Fri) 0.525 0.525 0.525 0.525 78,650
20th Nov 2025 (Thu) 0.525 0.525 0.525 0.525 1,061,732
19th Nov 2025 (Wed) 0.525 0.525 0.525 0.525 5,046
18th Nov 2025 (Tue) 0.525 0.525 0.525 0.525 98,114
17th Nov 2025 (Mon) 0.525 0.525 0.525 0.525 3,220
14th Nov 2025 (Fri) 0.55 0.55 0.525 0.525 888,495
13th Nov 2025 (Thu) 0.55 0.55 0.55 0.55 134,906
12th Nov 2025 (Wed) 0.55 0.55 0.55 0.55 321
11th Nov 2025 (Tue) 0.55 0.55 0.55 0.55 247
10th Nov 2025 (Mon) 0.55 0.55 0.55 0.55 3,363
7th Nov 2025 (Fri) 0.60 0.60 0.55 0.55 623,472
6th Nov 2025 (Thu) 0.55 0.55 0.55 0.55 252,646
5th Nov 2025 (Wed) 0.55 0.55 0.55 0.55 172,112
4th Nov 2025 (Tue) 0.55 0.55 0.55 0.55 37,039
3rd Nov 2025 (Mon) 0.55 0.55 0.55 0.55 52,083
See more Trellus Health. price history

Trellus Health. (TRLS) Regulatory News

Date Source Headline
24th Nov 2025 7:00 am RNS Finance update
7th Nov 2025 7:00 am RNS Contract signed with second leading CRO
22nd Oct 2025 7:00 am RNS Contract Signed with Leading Global CRO
21st Oct 2025 7:00 am RNS Company Update
8th Sep 2025 3:15 pm RNS Interim results - Replacement
8th Sep 2025 7:00 am RNS Interim results
3rd Sep 2025 7:00 am RNS Notice of Results
12th Aug 2025 7:00 am RNS Holding(s) in Company
1st Jul 2025 7:00 am RNS Result of AGM
30th Jun 2025 7:00 am RNS AGM Statement
See more Trellus Health. regulatory news

Trellus Health. (TRLS) Share News

Trellus Health shares jump as USD600,000 loan note extends cash runway

24th Nov 2025 11:51

(Alliance News) - Trellus Health PLC on Monday said it has entered into a USD600,000 unsecured loan agreement with its long-standing shareholder, Icahn School of Medicine at Mount Sinai. Read More

Trellus Health hails signing of contract with "leading" research firm

7th Nov 2025 14:17

(Alliance News) - Trellus Health PLC on Friday said it signed a contract with "one of the largest global clinical research organisations". Read More

TRADING UPDATES: Genflow patent progress; Accsys new debt facilities

22nd Oct 2025 22:20

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

IN BRIEF: Trellus Health reduces cash burn, financing talks continue

21st Oct 2025 19:55

Trellus Health PLC - London-based healthcare company - Says its cash runway now extends to early December, after cost-saving measures cut monthly cash burn to around USD395,000 from USD440,000. Talks continue re a potential equity fundraising to support the next phase of growth but there can be no certainty that any funding transaction will be concluded. No other near-term strategic opportunities have been identified at this time and it is unlikely that any can be identified before early December, Trellus adds. The company remains in late-stage contract talks with a leading global contract research organisation for a mid-stage clinical trial and has secured preferred vendor status with another. It expects to announce at least one new collaboration by the end of November and continues discussions with potential investors over a possible equity fundraising to support its next growth phase. Read More

AIM WINNERS & LOSERS: Eco Buildings wins "landmark" contract in Chile

21st Oct 2025 10:49

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More

See more Trellus Health. news
FTSE 100 Latest
Value9,687.43
Change-15.10

Login to your account

Forgot Password?

Not Registered